United States · FDA National Drug Code directory
Wynzora
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73499-001_22617d3b-9736-472b-bc08-1ce53fe151aa
- Product NDC
- 73499-001
- Form
- CREAM
- Composition / generic term
- Calcipotriene and Betamethasone dipropionate
- Labeler
- MC2 Therapeutics Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210630
- Source listing expiry
- 20261231
Source-listed ingredients
- CALCIPOTRIENE — 50 ug/g
- BETAMETHASONE DIPROPIONATE — 64 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (73499-001-01) / 60 g in 1 TUBE · 73499-001-01
- 10 TUBE in 1 CARTON (73499-001-03) / 5 g in 1 TUBE · 73499-001-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →